Hims & Hers Health targets $0.23 earnings per share this May

Hims & Hers Health, a prominent health company listed on the New York Stock Exchange as HIMS, is anticipated to unveil its earnings report on May 5, 2025. This earnings announcement is particularly noteworthy as analysts expect the company to achieve earnings per share of $0.23 accompanied by revenues reaching $538.4 million. When compared to the earnings report from the same quarter last year, which showed earnings of $0.10 per share on $278.2 million in revenue, this projection signals a significant increase, reflecting the company's robust customer growth and improved operational performance. Over the past few years, Hims & Hers has demonstrated considerable volatility in its stock prices surrounding its earnings announcements. In the last five years, they have recorded 16 earnings data points, yielding 7 positive and 9 negative returns within a one-day period post-earnings. The statistics indicate that positive returns were observed approximately 44% of the time, although this percentage drops slightly to 42% when analyzing the last three years. Notably, the median positive return was recorded at 13%, while the median of negative returns was at -5.8%. Traders often consider event-driven strategies that revolve around historical performance during earnings announcements. Some traders choose to position themselves before the earnings release based on analyzed probabilities from the past, while others may look at the relationship between immediate returns following earnings and medium-term returns to guide their trading strategy. For example, if the stock sees a positive return on the first day after earnings, a trader may opt to invest long-term for the subsequent five-day period. Hims & Hers, with a market capitalization of $7.7 billion and trailing twelve months of revenue totaling $1.5 billion, has demonstrated operational profitability, specifically showing operating profits of $62 million and a net income of $126 million. This financial stability underscores the potential for robust market reactions during forthcoming earnings reports, as traders and analysts alike remain eager to gauge how actual results will align with consensus estimates and overall market expectations.